Volume 13, Number 7—July 2007
Rickettsia parkeri in Brazil
Highlight and copy the desired format.
|EID||Silveira I, Pacheco RC, Szabó MP, Ramos HG, Labruna MB. Rickettsia parkeri in Brazil. Emerg Infect Dis. 2007;13(7):1111. https://dx.doi.org/10.3201/eid1307.061397|
|AMA||Silveira I, Pacheco RC, Szabó MP, et al. Rickettsia parkeri in Brazil. Emerging Infectious Diseases. 2007;13(7):1111. doi:10.3201/eid1307.061397.|
|APA||Silveira, I., Pacheco, R. C., Szabó, M. P., Ramos, H. G., & Labruna, M. B. (2007). Rickettsia parkeri in Brazil. Emerging Infectious Diseases, 13(7), 1111. https://dx.doi.org/10.3201/eid1307.061397.|
We report finding Rickettsia parkeri in Brazil in 9.7% of Amblyomma triste ticks examined. An R. parkeri isolate was successfully established in Vero cell culture. Molecular characterization of the agent was performed by DNA sequencing of portions of the rickettsial genes gltA, htrA, ompA, and ompB.
The first reported infection with Rickettsia parkeri was in Amblyomma maculatum ticks in Texas >65 years ago (1). Although its pathogenicity for humans was suspected or speculated during the following decades (2), R. parkeri was only recently recognized as a human tickborne pathogen (3). Extensive cross-reactivity exists among spotted fever group rickettsiae—especially R. rickettsii (the etiologic agent of Rocky Mountain spotted fever [RMSF] and Brazilian spotted fever [BSF])—and R. parkeri. Most of the time, R. rickettsii antigen is the only antigen used in serologic analysis for routine diagnosis of RMSF and BSF. Thus, many human cases of R. parkeri infection may be routinely misidentified as RMSF (2).
During the 1990s in Uruguay, several human cases of a tickborne rickettsiosis were diagnosed on the basis of serologic analyses; the spotted fever group organism R. conorii was used as antigen (4). Because R. conorii has never been found in the Western Hemisphere, another spotted fever group rickettsia may have been responsible for the reported cases (5). Because of recent reports of R. parkeri infection among A. triste ticks in Uruguay (where A. triste is the most common human-biting tick), this rickettsia has been suggested as the most probable agent of the Uruguayan spotted fever rickettsiosis (5,6). These data are corroborated by similar clinical findings found for both the American spotted fever caused by R. parkeri and Uruguayan spotted fever (2,4). R. parkeri has been reported only in the United States and Uruguay. We report R. parkeri infection of A. triste ticks in Brazil.
A. triste ticks were collected in a marsh area (21°07′06.7′′S, 51°46′06.5′′W) in Paulicéia County, state of São Paulo, Brazil. This area harbors a natural population of A. triste, mostly in the natural marsh environment along the Paraná River (7). Marsh deer (Blastocerus dichotomus) have been implicated as primary hosts for the adult stage of A. triste in the area, but the hosts for the immature stages of the tick remain unknown (7).
In January 2005, free-living adult A. triste ticks were collected by use of dry ice traps. Collected ticks were taken alive to the laboratory, where they were screened for rickettsial infection by using the hemolymph test with Gimenez staining (8). Immediately after hemolymph was collected, the ticks were stored at –80°C until used for further testing.
Ticks with hemolymph test results positive for infection with a Rickettsia-like organism were processed for isolation of Rickettsia in cell culture by using the shell vial technique (9). In brief, Vero cells were inoculated with tick body homogenate and incubated at 28°C. The level of cell infection was monitored by Gimenez staining of scraped cells from the inoculated monolayer; a rickettsial isolate was considered established after 3 passages, each reaching >90% of infected cells (9).
For cell isolation, a sample of 100%-infected cells from the fourth Vero cell passage was subjected to DNA extraction and thereafter tested by a battery of PCRs by using previously described primer pairs that targeted fragments of the rickettsial genes gltA, htrA, ompA, and ompB (10). Amplified products were purified and sequenced (9) and then compared with National Center for Biotechnology Information (NCBI) nucleotide BLAST searches (www.ncbi.nlm.nih.gov/blast).
Tick specimens with hemolymph test results negative for Rickettsia-like organisms were thawed and individually processed for DNA extraction by the guanidine isothiocyanate–phenol technique (11). PCR amplification of a rickettsial gene fragment (398 nt) of the citrate synthase gene (gltA) was attempted on DNA from each tick by using the primers CS-78 and CS-323, which were designed to amplify DNA from all known Rickettsia spp. (9). Tick samples shown by PCR to be positive were tested further by a second PCR, which used the primers Rr190.70p and Rr190.602n, which amplify a 530-nt fragment of most of the spotted fever group Rickettsia (12). PCR products of the expected sizes were purified and sequenced (9) and then compared with NCBI nucleotide BLAST searches.
A total of 31 adult specimens of A. triste ticks were collected in January 2005. Specimens from 3 of the 31 ticks contained Rickettsia-like organisms, as determined by the hemolymph test. PCR amplification of the remaining 28 tick specimens was negative for Rickettsia spp. A Rickettsia organism was successfully isolated from only 1 of the 3 ticks with positive hemolymph test results. The isolate, designated as At24, was successfully established in Vero cell culture. PCR performed on DNA extracted from infected cells yielded the expected PCR products for all reactions. After DNA sequencing, the generated sequences of 1093, 489, 479, and 775 nt for the gltA, htrA, ompA, and ompB genes, respectively, showed 100%, 99.8%, 100%, and 100% identity to corresponding sequences of R. parkeri Maculatum strain from the United States (GenBank accession nos. U59732, U17008, U43802, AF123717, respectively). Isolation attempts for the other 2 ticks with positive hemolymph test results were lost because of bacterial or fungal contamination. Nevertheless, remnants of ticks used to inoculate Vero cells were subjected to DNA extraction and tested by PCR for the gltA and ompA genes, as described above for ticks. Expected products were obtained from these PCR studies, and the generated sequences were 100% identical to the corresponding sequences of R. parkeri Maculatum strain (GenBank accession nos. U59732 and U43802, respectively). The frequency of R. parkeri infection among ticks examined in this study was 9.7% (3/31). Partial sequences (gltA, htrA, ompA, ompB) from R. parkeri strain At24 generated in this study were deposited into GenBank and assigned nucleotide accession nos. EF102236–EF102239, respectively.
Our report of R. parkeri infection of ≈10% of A. triste ticks from 1 area in the state of São Paulo highlights the possibility of R. parkeri causing human cases of spotted fever rickettsiosis in Brazil. However, in contrast to Uruguay, Brazil appears to have rare occurrences of A. triste and has never had a report of an A. triste bite in humans. In addition, no human case of spotted fever has been reported from sites within the known distribution area of A. triste in Brazil. On the other hand, an R. parkeri–like agent (strain Cooperi) was recently reported to have infected A. dubitatum ticks from a BSF-endemic area in São Paulo (9). Since A. dubitatum is a human-biting tick that is highly prevalent in many BSF-endemic areas (13), it is a potential candidate for transmission of R. parkeri to humans.
Spotted fevers caused by R. parkeri and by R. rickettsii differ in 2 ways: an eschar frequently occurs at the tick bite site in spotted fever cases caused by R. parkeri, and lymphadenopathy occurs in cases caused by R. parkeri. Because clinical descriptions of BSF (diagnosed solely by serologic testing that uses R. rickettsii antigen) with these specific clinical signs have been described recently in Brazil (14,15), human infections with R. parkeri may be occurring in this country. These clinical descriptions were from areas with large populations of A. dubitatum but no known occurrence of A. triste. Moreover, because R. rickettsii antigen has been the only antigen regularly used for diagnosis of BSF, human spotted fever cases due to R. parkeri or other spotted fever group rickettsiae may be misidentified as BSF in Brazil.
Our study demonstrated an exact concordance between ticks that were positive for Rickettsia-like organisms by the hemolymph test and those that were positive for rickettsial DNA by PCR. Previous studies in our laboratory (9–11) have demonstrated the same results or a slightly higher sensitivity of PCR for detection of rickettsiae in ticks.
Dr Silveira is a PhD student at the University of São Paulo. Her research interests have focused on the ecology of tickborne diseases.
We thank David H. Walker for reviewing the manuscript, Pastor Wellington for logistic support during field work, and Márcio B. Castro, Marcos V. Garcia, Viviane A. Veronez, Nancy Prette, Cássio Peterka, and Lucas F. Pereira for their valuable help during field collection of ticks.
This work was supported by the Fundação de Amparo à Pesquisa do Estado de São Paulo and the Conselho Nacional de Desenvolvimento Cientifico e Technologico, Brazil.
- Parker RR, Kohls GM, Cox GW, Davis GE. Observations of an infectious agent from Amblyomma maculatum. Public Health Rep. 1939;54:1482–4.
- Paddock CD. Rickettsia parkeri as a paradigm for multiple causes of tick-borne spotted fever in the Western Hemisphere. Ann N Y Acad Sci. 2005;1063:315–26.
- Paddock CD, Sumner JW, Comer JA, Zaki SR, Goldsmith CS, Goddard J, Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States. Clin Infect Dis. 2004;38:812–3.
- Diaz IA. Rickettsioses caused by Rickettsia conorii in Uruguay. Ann N Y Acad Sci. 2003;990:264–6.
- Parola P, Paddock CD, Raoult D. Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin Microbiol Rev. 2005;18:719–56.
- Venzal JM, Portillo A, Estrada-Peña A, Castro O, Cabrera PA, Oteo JA. Rickettsia parkeri in Amblyomma triste from Uruguay. Emerg Infect Dis. 2004;10:1493–5.
- Szabo MP, Castro MB, Ramos HG, Garcia MV, Castagnolli KC, Pinter A, Species diversity and seasonality of free-living ticks (Acari: Ixodidae) in the natural habitat of wild marsh deer (Blastocerus dichotomus) in Southeastern Brazil. Vet Parasitol. 2007;143:147–54.
- Burgdorfer W. Hemolymph test. A technique for detection of rickettsiae in ticks. Am J Trop Med Hyg. 1970;19:1010–4.
- Labruna MB, Whitworth T, Horta MC, Bouyer DH, McBride JW, Pinter A, Rickettsia species infecting Amblyomma cooperi ticks from an area in the state of São Paulo, Brazil, where Brazilian spotted fever is endemic. J Clin Microbiol. 2004;42:90–8.
- Pinter A, Labruna MB. Isolation of Rickettsia rickettsii and Rickettsia bellii in cell culture from the tick Amblyomma aureolatum in Brazil. Ann N Y Acad Sci. 2006;1078:523–9.
- Sangioni LA, Horta MC, Vianna MC, Gennari SM, Soares RM, Galvão MAM, Rickettsial infection in animals and Brazilian spotted fever endemicity. Emerg Infect Dis. 2005;11:265–70.
- Regnery RL, Spruill CL, Plikaytis BD. Genotypic identification of rickettsiae and estimation of intraspecies sequence divergence for portions of two rickettsial genes. J Bacteriol. 1991;173:1576–89.
- Labruna MB, Pacheco RC, Ataliba AC, Szabó MPJ. Human parasitism by the capybara tick, Amblyomma dubitatum (Acari: Ixodidae). Entomol News. 2007;118:77–80.
- Costa PSG, Assis RVC, Costa SMCR, Valle LMC, Brigatte ME. Three cases of spotted fever group rickettsiosis with typhus eschar–like lesion (tache noire) reported: species other than R. rickettsii at large? Rev Bras Parasitol Vet. 2004;13(Suppl):360.
- Madeira A. Surto de febre maculosa no estado de Santa Catarina. Rev Bras Parasitol Vet. 2004;13(Suppl):364.
Please use the form below to submit correspondence to the authors or contact them at the following address:
Marcelo B. Labruna, Departamento de Medicina Veterinária Preventiva e Saúde Animal, Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo, São Paulo, SP, Brazil 05508-270;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: June 18, 2010
- Page last updated: June 18, 2010
- Page last reviewed: June 18, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)